Skip to content

Physical Therapy in Shoulder Impingement Syndrome

Low-level Laser Therapy Versus Ultrasound Therapy Combined With Exercise in Patients With Subacromial Impingement Syndrome

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04779190
Enrollment
60
Registered
2021-03-03
Start date
2021-03-04
Completion date
2021-07-10
Last updated
2021-07-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Subacromial Impingement Syndrome

Brief summary

The aim of this study is to evaluate the effects of low-level laser therapy (LLLT) and therapeutic ultrasound combined with home-based exercise in comparison with home-based exercise alone in patients with subacromial impingement syndrome (SIS). Participants are going to evaluate before training, and at the 1-month follow-up and 3-month follow-up using the visual analog scale (VAS) scores for pain during activity, at rest, and at night, and the Shoulder Pain and Disability Index (SPADI).

Detailed description

SIS is an important cause of pain and disability and affects activities of daily living. Therefore, a major goal of SIS treatment is to reduce pain and improve upper extremity function. In this prospective, randomized controlled, single-blind, interventional trial, a total of 60 patients with SIS who met the eligibility criteria are going to enrolled in the study. Eligible participants are going to randomly assign to one of the three groups by an independent blinded researcher, using a computer-generated random numbers and allocation ratio of 1:1:1: the LLLT group (LG, n = 20), the ultrasound therapy group (UG, n = 20), and the control group (CG, n = 20). Participants are going to evaluate before training, and at the 1-month follow-up and 3-month follow-up using the visual analog scale (VAS) scores for pain during activity, at rest, and at night, and the Shoulder Pain and Disability Index (SPADI).

Interventions

DEVICELow-level laser therapy

Gallium-aluminum-arsenide diode laser device

DEVICETherapeutic ultrasound

Therapeutic pulsed ultrasound with a frequency of 1 MHz

OTHERHome-based exercise

Home-based exercises 3 days a week; each exercise comprises one set with 5 repetitions over 4 weeks.

Sponsors

Istanbul University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
30 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Clinical diagnosis of subacromial impingement syndrome based on physical examinations * Persistent pain in one shoulder for at least 2 months * No passive shoulder range of motion limitations * Failure of improvement in pain after analgesic medications

Exclusion criteria

* History of malignancy and systemic rheumatic diseases * Evidence of systemic or local infection * Presence of major trauma at the affected shoulder * History of shoulder surgery * Rotator cuff lesions in the form of either calcific tendinosis or full-thickness tear as confirmed on MRI scanning

Design outcomes

Primary

MeasureTime frameDescription
Change from baseline activity pain score at 1-months and 3-monthsBaseline, 1-month, 3-monthVisual Analogue Scale-Activity pain (0-10 point). Higher scores mean a worse outcome

Secondary

MeasureTime frameDescription
Change from baseline rest pain score at 1-months and 3-monthsBaseline, 1-month, 3-monthVisual Analogue Scale-Rest pain (0-10 point). Higher scores mean a worse outcome
Change from baseline Shoulder Pain and Disability Index at 1-months and 3-monthsBaseline, 1-month, 3-monthShoulder Pain and Disability Index (SPADI) measures shoulder pain and shoulder disability. Total score ranges from 0 to 130, where a higher score indicates a worsening status. Each item is scored with the VAS, which ranges from 0 (no pain or no difficulty) to 10 (worst pain imaginable or very difficult, help required)
Change from baseline night pain score at 1-months and 3-monthsBaseline, 1-month, 3-monthVisual Analogue Scale- Night pain (0-10 point). Higher scores mean a worse outcome

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026